526 related articles for article (PubMed ID: 28199071)
1. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
[TBL] [Abstract][Full Text] [Related]
2. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
Carbon M; Hsieh CH; Kane JM; Correll CU
J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
van Harten PN; Matroos GE; Hoek HW; Kahn RS
Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
[TBL] [Abstract][Full Text] [Related]
4. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
van Harten PN; Hoek HW; Matroos GE; van Os J
J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
[TBL] [Abstract][Full Text] [Related]
5. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Carbon M; Kapoor S; Sheridan E; Al-Jadiri A; Azzo S; Sarkaria T; Kane JM; Saito E; Correll CU
J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):718-727.e3. PubMed ID: 26299293
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
[TBL] [Abstract][Full Text] [Related]
7. Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV.
Willems AE; Mentzel CL; Bakker PR; Van Os J; Tenback DE; Gelan P; Daantjes E; Matroos GE; Hoek HW; Van Harten PN
Schizophr Bull; 2022 Jun; 48(4):766-773. PubMed ID: 35486807
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
Seigneurie AS; Sauvanaud F; Limosin F
Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
[TBL] [Abstract][Full Text] [Related]
9. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
Chan CH; Chan HY; Chen YC
Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
[TBL] [Abstract][Full Text] [Related]
10. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
[TBL] [Abstract][Full Text] [Related]
11. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia.
Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T
Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia in the aged. Duration of treatment relationships.
Toenniessen LM; Casey DE; McFarland BH
Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
14. Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis.
Mentzel TQ; van der Snoek R; Lieverse R; Oorschot M; Viechtbauer W; Bloemen O; van Harten PN
J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30257080
[TBL] [Abstract][Full Text] [Related]
15. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk factors for the development of tardive dyskinesia.
Solmi M; Pigato G; Kane JM; Correll CU
J Neurol Sci; 2018 Jun; 389():21-27. PubMed ID: 29439776
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosis.
Hansen TE; Weigel RM; Brown WL; Hoffman WF; Casey DE
J Neuropsychiatry Clin Neurosci; 1992; 4(1):29-35. PubMed ID: 1352714
[TBL] [Abstract][Full Text] [Related]
19. Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
Garcia-Amador M; Merchán-Naranjo J; Tapia C; Moreno C; Castro-Fornieles J; Baeza I; de la Serna E; Alda JA; Muñoz D; Andrés Nestares P; Cantarero CM; Arango C
J Clin Psychopharmacol; 2015 Dec; 35(6):686-93. PubMed ID: 26505569
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
Akbostanci MC; Atbaşoğlu EC; Balaban H
Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
